Allos Therapeutics, Inc. (NASDAQ:ALTH)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Recs

0
Player Avatar JohanHansen (75.54) Submitted: 2/16/2010 12:12:34 AM : Outperform Start Price: $7.25 ALTH Score: -97.24

3CmbA,200A,C2N

Report this Post Reply

Featured Broker Partners


Advertisement